New inhibitors of dipeptidyl peptidaseIII (EC 3. 4. 14. 4) from human placenta, designated as fluostatins A and B, were discovered in the fermentation broth of a strain isolated in our institute. The strain has been identified as Streptomyces sp. TA-3391 on the basis of taxonomic studies. Fluostatins A and B were purified by Diaion HP-20 chromatography, ethyl acetate extraction, silica gel chromatography and reverse phase preparative HPLC.
slightly inhibitory against other dipeptidyl peptidases. Fluostatin A showed mixed-type (competitive and noncompeptitive) inhibition with human leucine-enkephalin as a substrate, Dipeptidyl peptidases1) (DPPs), which catalyze the sequential release of dipeptides from the NH2 terminus of peptide substrates, have been identified as at least 4 distinct enzyme proteins from various mammalian tissues. Dipeptidyl peptidase III (EC 3. 4. 14. 4, DPP-III), classified by the preferential cleavage of L-arginyl-Larginine, has been purified from the cytosolic fractions of bovine pituitary gland2), rat skin3), and other Human placental DPP-III seems to require both cysteine residue(s) and metal ion(s) in its catalytic process because of the sensitivity to various peptidase inhibitors7). Its proteolytic activity was stimulated by Co2+, and the stimulant ratio was dependent on the Co2+ concentration in a saturable manner8). The physiological functions of DPP-III are still unclear, but it has been proposed to play a role in the regulation of hormonal peptides such as angiotensin6) and/or enkephalin6,8) because of the ability to degrade these peptides in vitro. 
Analytical Instruments
Inhibitory activities of fluostatins were measured with a BIO-RAD microplate reader model 3550. HPLC was performed with a Gilson system. MPs were taken using a Yanaco MP-500D apparatus and were uncorrected. Optical rotations were measured on a Perkin-Elmer 241 polarimeter using micro-cell (light path 10cm). UV spectra were recorded on a Hitachi U-3210 spectrophotometer, and IR spectra on a Hitachi I-5020 FT-IR spectrophotometer. MS spectra were obtained on a JEOL JMS-SX 102 mass spectrometer. DPP-I and DPP-II were prepared from rat spleen homogenate as described by METRIONE et al.9) and MCDONALD et al.10), respectively. DPP-IV was prepared from rat kidney homogenate as described by OYA et al.11).
Assay for Enzyme and Inhibitory Activity
With synthetic substrates, DPP-I, -II, -III, and -IV activities were measured by minor modifications of the methods of METRIONE et al.11), MCDONALD et al.12), SHIMAMORI et al.7) and OYA et al.11), respectively. The principle of these assays for DPPs is based on the absorbance at 525nm of a chromophoric complex of the 2-naphthylamine hydrolysed from these synthetic substrates. This is measured with a microplate reader. The for 10 minutes and then incubated with substrate (3.2 mM) for 1 hour.
The percent inhibition was calculated by the formula in the assay system without an inhibitor and B is that with an inhibitor. The IC50 value is the concentration of an inhibitor that gives at 50% inhibition of the enzyme activity.
With human leucine-enkephalin (Tyr-Gly-Gly-PheLeu) as substrate, DPP-III activity was assayed by the method of C. -M. LEE et al.6). The activity was detected as a peak of glycyl-phenyl-leucine at 210nm with a Gilson HPLC system on a packed column of Capcell Pak C18. 
Production of Fluostatins A (1) and B (2)
The strain TA-3391 was inoculated into 110ml of a seed medium consisting of glycerol 2.0%, Bacto-soytone (Difco) 2.0%, and CaCO3 (pH adjusted to 7.4 with 2N NaOH before sterilization) in a 500-ml baffled Erlenshaker (180rpm). After incubation, two-ml of this seed medium was transferred to 110ml of the fresh medium in the same type of flask and cultured under the same THE JOURNAL OF ANTIBIOTICS Table  1 . Cultural characteristics of strain TA-3391. condition as above until the production reached maximum.
The time course of the production in the broth was measured (Fig. 2) . Residual glycerol in the cultivated broth were measured according to D. J. HANAHAN et al.13 ). The maximum level of fluostatins was obtained at 40 hours and was maitained thereafter. The amount of residual glycerol was decreased as the production of the inhibitors increased.
Two hundred-ml portions of seed medium were inoculated into sixty 500-ml Erlenmeyer flasks containing 110ml of the same fresh medium and cultured for 40 hours as described above.
Isolation of Fluostatins A (1) and B (2)
The isolation scheme of 1 and 2 is summarized in Fig. 3 .
The culture broth (6.0 liters) was filtered and separated into the mycelial cake and culture filtrate (5.8 liters). The broth filtrate was adsorbed onto a Diaion HP-20 column .
The column was washed with water and eluted with 50% aqueous acetone. The active fractions were pooled and concentrated in vacuo to remove acetone . The solution was adjusted to pH 3.0 with concentrated HCl and extracted twice with an equal volume of ethyl acetate pressure to give a brown residue (1.25g). The residue was suspended in chloroform-acetic acid (100:1) and was charged on a silica gel column (Wakogel C-200, 50g), washed with the same solution, and developed with chloroform-methanol-acetic acid (98:2:1) to give first
The color names used in this table were based on the Color Harmony Manual (Container Corporation of America , Illinois). active fraction (fraction 1), and then developed with chloroform-methanol-acetic acid (95:5:1) to give second active fraction (fraction 2).
The fraction 1 was evaporated to dryness to give a brown powder (102mg), which was applied to a reverse rate 8ml/minute, Gilson system), and eluted with a solvent mixture of aqueous 27% acetonitrile containing 1% acetic acid. The fractions containing 1 (Fig. 1-1) were concentrated under reduced pressure to give a dark brown solid (1.8mg). This solid was not soluble in various solvents, even dimethyl sulfoxide. Therefore, further purification was done by converting the free acid to the sodium salt. The solid was suspended in methanol (0.9 ml) and was added to saturated aqueous sodium hydrogen carbonate (0.1ml). The resulting clear solution was diluted immediately with deionized water (25ml) and was adsorbed onto Diaion HP-20 culumn (5ml), washed with 10% aqueous acetone, and then eluted with 30%
The eluate was concentrated to dryness under reduced pressure, and then the residue was crystallized from methanol (5ml) to give the sodium salt of pure 1 (1.1mg, 1-Na) as purple needles.
The fraction 2 containing 2 ( Fig. 1-2 ) was evaporated to dryness to give a orange powder (288mg). After crystallization from methanol (30ml), pure 2 (237mg) was obtained as orange rods. insoluble in chloroform and water. 2 is partially soluble in acetone and ethyl acetate, and 1-Na is insoluble in these solvents. On the basis of HRFAB-MSs and elemental analyses, the molecular formulae of 1 and 2 were determined to be C18H10O5 and C18H14O6, respectively.
Physico-chemical Properties of Fluostains
Physico-chemical properties of these compounds are summarized in Table 3 . Both structures of these compounds ( Fig. 1) contain a fluorenone moiety. Structure determination of 1 and 2 will be described in the following paper14).
Biological Activities of Fluostatins A
(1-Na) and B (2)
The inhibitory activities of 1-Na and 2 to DPPs are shown in Table 4 . The IC50 values of 1-Na and 2 to compounds were only slightly inhibitory to other DPPs (data not shown). We examined whether or not 1-Na inhibited the hydrolysis of human leucine-enkephalin by DPP-III in THE JOURNAL OF ANTIBIOTICS JUNE 1998 Table 3 . Physico-chemical properties of fluostatins A (1, sodium salt) and B (2). Table 4 . Inhibitory activities of fluostatins A (1, sodium salt) and B (2) to dipeptidyl peptidases.
1-Na and 2 showed very weak antimicrobial activities against bacteria and fungi (Data not shown). And both compounds had low toxicity; there were no deaths after an ip injection in mice of 100mg/kg.
These data suggested that 1 is a potent and selective inhibitor of DPP-III in vitro. Both 1 and 2, contained a fluorenone skelton and are unique non-peptide in- 
